Adma Biologics (ADMA) Total Debt Growth (3y) (2015 - 2025)
Adma Biologics (ADMA) Total Debt Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 50.25% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 25.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -20.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.36% |
| Sep 30, 2025 | -19.98% |
| Jun 30, 2025 | -19.33% |
| Mar 31, 2025 | -19.38% |
| Dec 31, 2024 | -8.64% |
| Sep 30, 2024 | 2.40% |
| Jun 30, 2024 | 11.77% |
| Mar 31, 2024 | 11.89% |
| Dec 31, 2023 | 11.99% |
| Sep 30, 2023 | 18.66% |
| Mar 31, 2023 | 21.12% |
| Dec 31, 2022 | 112.39% |
| Sep 30, 2022 | 27.73% |
| Jun 30, 2022 | 110.96% |
| Mar 31, 2022 | 110.30% |
| Dec 31, 2021 | 46.78% |
| Sep 30, 2021 | 53.38% |
| Jun 30, 2021 | 84.87% |
| Mar 31, 2021 | 223.47% |
| Dec 31, 2020 | 222.96% |